MedPath
NMPA Approval

Dapagliflozin Tablets

国药准字H20253768

April 1, 2025

Drug Information

达格列净片

片剂

5mg(按C₂₁H₂₅ClO₆计)

化学药品

April 1, 2025

Company Information

Applicant Company

江苏省海门经济技术开发区定海路688号

Manufacturing Company

江苏省海门经济技术开发区定海路688号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达格列净片 - NMPA 批准文号 | MedPath